A groundbreaking trial explores personalized endocrine therapy for early-stage breast cancer, aiming to reduce chemotherapy's ...

Transparent expectation-setting and addressing potential disappointments can foster safety, reduce anxiety, and promote ...

Marketing of MIMEDX’s Leading Placental Allograft Portfolio and Vaporox’s Vaporous Hyperoxia Treatment DeviceMARIETTA, Ga., ...

Modern chatbots can simulate the majority of psychotherapy features as defined by standard definitions. It might be time for ...

MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") and Vaporox, Inc. ("Vaporox") today jointly announced a ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of the ...

Hospitalists working in behavioral health centers face unique challenges, including limited resources and complex patient ...

ABA therapy centers in Middle River and Owings Mills expand access to high-quality, early intervention services for young children with autismSILVER SPRING, Md., July 31, 2025 (GLOBE NEWSWIRE) -- ...

On a cold fall day sometime during the height of COVID, our family received the unexpected gift of new friendship. A lovely family made the bold ...

Allogene Therapeutics has reported a patient death tied to its anti-CD52 monoclonal antibody used for lymphodepletion in its ...

Sanofi’s Sarclisa receives European approval to treat transplant-eligible newly diagnosed multiple myeloma: Paris Saturday, July 26, 2025, 09:00 Hrs [IST] Following the positive ...

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma  Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction ...